India, April 27 -- Shares of Veradermics, Incorporated (MANE) are surging about 44 percent during Monday morning trading after the company announced positive topline results in the Phase 2/3 trial for VDPHL01, an oral formulation of minoxidil for treating male pattern hair loss.
The company's shares are currently trading at $97.67 on the New York Stock Exchange, up 44.18 percent. The stock opened at $81.07 and has climbed as high as $101.81 so far in today's session. Over the past year, it has traded in a range of $32.00 to $101.81.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....